The Kanabo share price is surging! Time to buy?

After months of lacklustre performance, the Kanabo share price is finally on the rise. Zaven Boyrazian investigates what’s behind this growth.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After months of idle and lacklustre performance, the Kanabo (LSE:KNB) share price is finally on the rise. In fact, over the last couple of weeks, the medical cannabis stock is up by nearly 80%! What’s behind this new-found growth? And is it time to adding this company to my portfolio? Let’s take a look.

The rising Kanabo share price

Since the last time I looked at this business, quite a few developments have taken place. As a quick reminder, Kanabo develops and manufactures cannabidiol-based products (like oils) for the health & wellness sector. It combines the sale of these oils with its proprietary inhalation device, VapePod, effectively creating a Gillette-style razor & blade business model. If successful, I think Kanabo’s share price could see some considerable growth.

Last month, the company announced the shipment of its first medicinal cannabis cartridges to the UK. These were produced with the help of its partner PharmaCann Polska. And thanks to the partnership with Astral Health, access to patients in need of such a product has been relatively straightforward.

Moreover, because doctors can prescribe specific doses with the VapePod devices (something not possible with the traditional smoking approach), Kanabo’s product seems to have several advantages for medicinal purposes. But besides revenue finally coming in, this successful product launch also proves that its supply and production pipeline works. So, I’m not surprised to see Kananbo’s share price rising on the news.

More growth comes with more risk

Now that a customer base has been established, the management team wants to act rapidly through strategic acquisitions. Towards the end of July, the company proposed acquiring the European firm, Materia. Besides having a Good Manufacturing Practice (GMP) certification, Materia owns a licensed medical cannabis wholesaler in Germany. By purchasing the business, Kanabo would gain access to an already established network of pharmacies as a new sales channel.

That certainly sounds like a good move. However, acquisitive growth strategies have their risks. Firstly, the management team intends to sell additional Kanabo shares to fund the proposed deal since the lack of profitability makes debt financing unsuitable. That will lead to a potentially significant amount of equity dilution, pushing Kanabo’s share price down.

What’s more, there is no guarantee this deal will be successful. Integrating a company into another often leads to complications that can destroy value rather than create it. With Kanabo’s limited history and experience performing acquisitions, the risk of integration pains seems high, in my opinion.

The Kanabo share price has its risks

The bottom line

Since its IPO last February, Kanabo has been slowly turning into what looks like a viable business. The partnerships formed in the past few months have already started to bear fruit. And with certification being received for its products, it seems the company has managed to overcome the initial challenges it faced. That’s encouraging news for Kanabo’s share price.

Having said that, I’m still on the fence as to whether this is a business worth owning. On an operational level, it looks like it’s in a solid position. However, there remains an aura of mystery surrounding its financials. With limited information about its most recent sales volume and price, Kanabo remains difficult to judge, in my mind. Therefore, I’m keeping it on my watchlist for now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »